Back
Appili Therapeutics Vs. Lexaria Bioscience Industry Stock Comparison
Sell
29
APLIF
Appili Therapeutics
Last Price:
0.02
Seasonality Move:
-9.36%
Sell
19
LEXX
Lexaria Bioscience
Last Price:
2.00
Seasonality Move:
9.56%
Sell
29
Appili Therapeutics (APLIF)
is a Sell
Is Appili Therapeutics a Buy, Sell or Hold?
- The current Appili Therapeutics [APLIF] share price is $0.02. The Score for APLIF is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- APLIF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Lexaria Bioscience (LEXX)
is a Sell
Is Lexaria Bioscience a Buy, Sell or Hold?
- The current Lexaria Bioscience [LEXX] share price is $2.01. The Score for LEXX is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- LEXX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
APLIF Stock Price Chart
What is Appili Therapeutics's stock price today?
-
The Appili Therapeutics share price today is $0.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLIF is experiencing selling pressure, which indicates risk of future bearish movement.
LEXX Stock Price Chart
What is Lexaria Bioscience's stock price today?
-
The Lexaria Bioscience share price today is $2.01
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LEXX is experiencing slight selling pressure.
APLIF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 46.37 | Sell |
Chaikin Money Flow: | 118182 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.03 - 0.03) | Sell |
Bollinger Bands (100): | (0.03 - 0.03) | Sell |
LEXX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.21 | Sell |
Relative Strength Index (14 RSI): | 26.93 | Sell |
Chaikin Money Flow: | -62468 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.19 - 2.79) | Sell |
Bollinger Bands (100): | (2.56 - 3.42) | Sell |
APLIF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.02 | Sell |
20-day SMA: | 0.03 | Sell |
50-day SMA: | 0.02 | Sell |
200-day SMA: | 0.03 | Sell |
8-day EMA: | 0.02 | Sell |
20-day EMA: | 0.03 | Sell |
50-day EMA: | 0.03 | Sell |
200-day EMA: | 0.03 | Sell |
LEXX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.23 | Sell |
20-day SMA: | 2.38 | Sell |
50-day SMA: | 2.85 | Sell |
200-day SMA: | 3.02 | Sell |
8-day EMA: | 2.21 | Sell |
20-day EMA: | 2.39 | Sell |
50-day EMA: | 2.7 | Sell |
200-day EMA: | 2.77 | Sell |
Appili Therapeutics Earnings Growth & APLIF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Lexaria Bioscience Earnings Growth & LEXX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and an increase next year of $0.09 per share.
Appili Therapeutics Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Lexaria Bioscience Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |